A peptide-library plan needs a rule for the end of a protein sequence. A neat stepping pattern can leave a short uncovered tail. Deciding what to do with that tail before ordering prevents an unintended gap.
Count the regular windows
Take a hypothetical sequence of 52 residues, a peptide length of 15 and a step of 10. Complete regular windows start at positions 1, 11, 21 and 31. They cover residues 1–15, 11–25, 21–35 and 31–45. The regular full-length count is floor((52 − 15) ÷ 10) + 1 = 4.
The tail requires a choice
Residues 46–52 are not covered by those four windows. Adding a terminal full-length window at 38–52 covers the tail, but its overlap differs from the regular pattern. Another approach might use a shorter terminal peptide. These are design choices, not equivalent formats.
Why the choice affects the experiment
A shorter peptide can have different presentation and properties. A shifted full-length terminal peptide changes the overlap pattern. If analysis expects a uniform step, that change must be recorded. Do not silently add or remove a peptide after the layout has been approved.
Make the order list explicit
Provide sequence identifiers, start and end coordinates, length and the terminal-window rule. Check that every intended residue is covered. Pair this with the existing library design guide rather than replacing it with a count alone. Feasibility, purification and per-sequence documentation must be confirmed for a custom enquiry.
Related materials and next steps
For a sequence or library project, begin with our custom peptide synthesis enquiry page. Describe the exact structure, quantities and analytical requirements; project feasibility and delivery scope need confirmation.
Send the product or sequence, quantity and document requirements. For more background, browse the analytical methods guides and research glossary.
Sources and reading scope
Source links checked 5 October 2026. Research summaries use the accessible original abstract unless a full-text source is explicitly identified. Guidance documents and external supplier explanations are technical references, not NHD batch evidence or a claim of regulatory compliance. Any example introduced as hypothetical or teaching is a calculation, not a measured product result.
NHD catalogue materials are for qualified laboratory research, development and manufacturing enquiries. This article does not provide instructions for human or veterinary use.
Sources & editorial method
AI-assisted writing and source checks; conceptual illustrated cover.
1 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
Study results and labeled examples are separated. Original-source, arithmetic, readability and internal-link checks; no independent human peer review recorded.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
- Overlapping Peptide LibraryOverlapping Peptide Library
Continue with structured records
Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.






KPV
BPC-157